Organon & Co. Announces Merger Agreement with Sun Pharma—Key Details from July 2026 SEC 8-K Filing
Organon & Co. 8-K Filing: Detailed Investor Analysis O...
Sign in to continue:
Organon & Co. 8-K Filing: Detailed Investor Analysis O...
Gogo Inc. Files Form 8-K: No Material Price-Sensitive Events...
Frontier Group Holdings, Inc. - Director Resignation Fro...
Trans American Aquaculture, Inc. Issues Non-Reliance Notice ...
Grayscale Avalanche Staking ETF: Material U.S. Federal Incom...
ARS Pharmaceuticals, Inc. 8-K Report: Key Leadership Changes...
Grayscale Ethereum Staking Mini ETF: Material U.S. Federal I...
Csquare, Inc. 8-K Filing: IPO, Registration Rights, and Gove...
Grayscale Ethereum Staking ETF: Material U.S. Federal Income...
Clover Health Reports Cybersecurity Incident: Key Details fo...